Tasmanian Drug Strategy

Tasmanian Drug Strategy

Tasmanian Drug Strategy 2021-2027

The Tasmanian Government is developing a new Tasmanian Drug Strategy 2021-2027 (TDS), through the Interagency Drug Policy Committee (IDPC) (formerly the Interagency Working Group on Drugs). The IDPC will also be responsible for the implementation of the TDS through the TDS Advisory Group.

The TDS will provide the higher-level whole-of-government and whole-of-community strategic framework to guide collaborative action and activities across agencies and organisations.

Its purpose is also to provide a guide for other agencies and organisations to consider the impacts of alcohol, tobacco and other drugs (ATOD) use and harm in their strategic policy responses.

The TDS vision is a Tasmania where people make healthy choices around ATOD use and can access support where and when they need it.

It will be consistent with the harm minimisation approach of the National Drug Strategy 2017-2026 and will support actions under the three pillars of supply, demand and harm reduction.

The TDS will acknowledge that preventing and reducing the risks and harms associated with ATOD use can only be achieved through whole-of-government, whole-of-community, multi-agency, community sector and individual collaboration and coordinated approaches.

It will provide the strategic framework for key action areas and activities to be undertaken to minimise the risks and harms associated with ATOD use in Tasmania.

Action areas and activities will be high level; for example, the development of a new Tasmanian Alcohol Action Plan is an activity under the alcohol action area, expected to be developed in 2021. It will identify specific activities and actions in response to alcohol-related use and harms in Tasmania.

The TDS itself will identify high-level population indicators of ATOD-related use and harms, for example the action areas will measure prevalence and trends in use and availability as well as numbers and percentage changes in harms such as deaths, emergency department and hospital presentations, motor vehicle crashes, and people in treatment.

Consultation and feedback processes

The Interagency Drug Policy Committee has agreed to a two-phase consultation process.  The first phase has commenced with consultation by member agencies and organisations through their internal relationship stakeholders on the general directions proposed for the TDS in line with the two-page Summary Paper available here.

Feedback from that process will inform the final content of the consultation draft TDS.  A second public consultation phase will be undertaken on that draft, following approval of the Minister for Mental Health and Wellbeing.

This website will be used to provide information and updates. A feedback process and portal on the public consultation draft TDS will be established and stakeholders informed.

Fact sheets have been developed and will be added to as appropriate.  Copies of these can be found below.

Queries can be directed to the Mental Health, Alcohol and Drug Directorate director.mhadd@health.tas.gov.au with ‘Tasmanian Drug Strategy’ in the subject line.

Fact Sheets